These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16584523)

  • 1. Prolonged follow-up of multinodular goitre patients treated with radioiodine preceded or not by human recombinant TSH.
    Cardia MS; Rubio IG; Medeiros-Neto G
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):474. PubMed ID: 16584523
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant human TSH associated with radioiodine does not have further effects on thyroid volume and function after 2 years.
    Paz-Filho GJ; Mesa CO; Carvalho GA; Goedert CA; Graf H
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):345-6. PubMed ID: 18167135
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
    Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
    Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of recombinant human thyrotropin, in normal subjects and patients with goitre.
    Nielsen VE; Bonnema SJ; Hegedüs L
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):655-63. PubMed ID: 15579178
    [No Abstract]   [Full Text] [Related]  

  • 5. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
    Bonnema SJ; Nielsen VE; Hegedüs L
    Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards larger volume reduction of nodular goitres by radioiodine therapy: a role for pretreatment with recombinant human thyrotropin?
    Huysmans DA; Nieuwlaat WA; Hermus AR
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):297-9. PubMed ID: 15008993
    [No Abstract]   [Full Text] [Related]  

  • 8. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter.
    Bonnema SJ; Hegedüs L
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):379-84. PubMed ID: 19623060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
    Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
    Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
    Cubas ER; Paz-Filho GJ; Olandoski M; Goedert CA; Woellner LC; Carvalho GA; Graf H
    Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin.
    Rubio IG; Silva MN; Knobel M; Romão R; Possato R; Gebrin EM; Buchpiguel C; Medeiros-Neto G
    J Endocrinol Invest; 2007; 30(7):535-40. PubMed ID: 17848834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.
    Fast S; Nielsen VE; Bonnema SJ; Hegedüs L
    Eur J Endocrinol; 2009 Apr; 160(4):517-28. PubMed ID: 19106244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.
    Bonnema SJ; Nielsen VE; Hegedüs L
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6113-4; author reply 6114-5. PubMed ID: 14671219
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of radioiodine therapy in benign nodular goitre.
    Bonnema SJ; Fast S; Hegedüs L
    Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):619-31. PubMed ID: 25047210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH.
    Fast S; Bonnema SJ; Hegedüs L
    Ann Endocrinol (Paris); 2011 Apr; 72(2):129-35. PubMed ID: 21513911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular assessment of hyperthyroid patients with multinodular goiter before and after radioiodine treatment preceded by stimulation with recombinant human TSH.
    Barca MF; Gruppi C; Oliveira MT; Romão R; Cárdia MS; Rubio I; Knobel M; Medeiros-Neto G
    Endocrine; 2007 Oct; 32(2):175-81. PubMed ID: 18026694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of recombinant human TSH in the management of large euthyroid multinodular goitre: a new therapeutic option? Pros and cons.
    Ceccarelli C; Brozzi F; Bianchi F; Santini P
    Minerva Endocrinol; 2010 Sep; 35(3):161-71. PubMed ID: 20938419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to and treatment of goiters.
    Medeiros-Neto G; Camargo RY; Tomimori EK
    Med Clin North Am; 2012 Mar; 96(2):351-68. PubMed ID: 22443980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy of euthyroid multinodular goitres.
    Manders JM; Corstens FH
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S466-70. PubMed ID: 12192547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use for recombinant human TSH in patients with toxic and non-toxic nodular goiter].
    Jedrzejuk D; Milewicz A
    Postepy Hig Med Dosw (Online); 2005 May; 59():188-92. PubMed ID: 15928602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.